This patent covers the induction of mesenchymal stem cell differentiation by activation of a ligand called ALCAM. Mesenchymal stem cells can differentiate into a wide variety of non-hematopoietic tissues and are useful for many clinical applications since they can be transplanted across allogeneic barriers, therefore knowing how to modulate their differentiation...
This patent covers the use of hedgehog proteins and various analogues for maintaining neuron and neuronal stem cell viability. The claims cover specific compositions of matter, whereas the specification teaches various means of using the compositions of matter for protecting dopaminergic neurons from cell death.
The basis of this patent is described in another
This patent covers the composition of matter for specific variants of erythropoietin, the renal secreted hormone responsible for generation of erythrocyte differentiation from bone marrow hematopoietic stem cells. Specifically, the patent covers variants of the erythropoietin molecule in which the amino acid cysteine is substituted for amino acids that are not essential for erythropoietin...
This patent teaches ways of generating dendritic cells from human hematopoietic stem cells and furthermore teaches how to pulse these dendritic cells with tumor antigens for use as cancer vaccines. This approach is similar in some ways to work performed by Eli Gilboa and the company Argos Therapeutics.
This patent teaches methods of introducing materials into cells. It is useful for introducing genes into cells to cause differentiation, or alternatively introducing cytoplasm of embryonic stem cells into adult cells in order to "rejuvenate" them.
This patent provides compositions for treatment of skin defects, including burn wounds, through culture and diffentiation of keratinocyte stem cells, and subsequent administration of the keratinocyte stem cells in vivo.
This patent teaches the utilization of ligands that activate gp130 for the induction of differentiation of embryonic germ stem cells.
This patent teaches how to use bone marrow stromal cells (are they similar to mesenchymal stem cells??) for generation of artificial bone. The use of various matrices, including ceramic powder is disclosed for practicing this invention.
This patent covers the use of hematopoietic stem cells to generate dendritic cells. The dendritic cells disclosed are able to elicit an antitumor immune response.
Disclosed in this patent are methods of generating antigen-loaded dendritic cells useful for cancer immunotherapy, through the differentiation of hematopoietic stem cells.